Literature DB >> 10661735

The future of bacterial vaginosis-related research.

D Taylor-Robinson1.   

Abstract

Various ways and criteria are used to diagnose BV. Guidelines should be redrawn and they should embody greater uniformity. The etiology of BV remains enigmatic. However, various observations suggest that host factors, possibly hormonal, cause an imbalance in the vaginal microflora. Exogenous factors, such as semen and antibiotics, may then help to bring about a more prolonged change. This forms a working hypothesis for further exploration. The role of the lactobacillus phage in the development of BV also needs to be determined. Various conditions may occur as a consequence of BV in non-pregnant and pregnant women and BV may also affect men. A subjective assessment of the extent to which these associations occur or are likely to be shown to occur by further investigations is presented in Table 1. The ability to cure acute BV needs to be improved as does the treatment of chronic BV, for which vaginal recolonization with exogenous lactobacilli is an approach to be evaluated further.

Entities:  

Mesh:

Year:  1999        PMID: 10661735     DOI: 10.1016/s0020-7292(99)00137-x

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

1.  The vaginal microbiome in health and disease.

Authors:  Bryan A White; Douglas J Creedon; Karen E Nelson; Brenda A Wilson
Journal:  Trends Endocrinol Metab       Date:  2011-07-13       Impact factor: 12.015

2.  Relative performance of three methods for diagnosing bacterial vaginosis during pregnancy.

Authors:  Vijaya K Hogan; Jennifer F Culhane; Jane Hitti; Virginia A Rauh; Kelly F McCollum; Kathy J Agnew
Journal:  Matern Child Health J       Date:  2007-09-15

3.  Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women.

Authors:  L Morison; G Ekpo; B West; E Demba; P Mayaud; R Coleman; R Bailey; G Walraven
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.